Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $329000.0.

  • InspireMD's Capital Expenditures fell 2185.27% to $329000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 2059.72%. This contributed to the annual value of $1.4 million for FY2024, which is 26797.9% up from last year.
  • According to the latest figures from Q3 2025, InspireMD's Capital Expenditures is $329000.0, which was down 2185.27% from $576000.0 recorded in Q2 2025.
  • In the past 5 years, InspireMD's Capital Expenditures ranged from a high of $576000.0 in Q2 2025 and a low of $25000.0 during Q1 2023
  • Moreover, its 5-year median value for Capital Expenditures was $157000.0 (2021), whereas its average is $203368.4.
  • Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 6086.96% in 2023, then surged by 95555.56% in 2024.
  • Over the past 5 years, InspireMD's Capital Expenditures (Quarter) stood at $107000.0 in 2021, then decreased by 11.21% to $95000.0 in 2022, then soared by 126.32% to $215000.0 in 2023, then skyrocketed by 44.65% to $311000.0 in 2024, then grew by 5.79% to $329000.0 in 2025.
  • Its Capital Expenditures was $329000.0 in Q3 2025, compared to $576000.0 in Q2 2025 and $359000.0 in Q1 2025.